Rise in BP w/ sympathomimetic agents eg, decongestants, TCAs, appetite suppressants & amphetamine-like psychostimulants or w/ MAOIs. Partially reversed hypotensive action of drugs interfering w/ sympathetic activity including bretylium, betanidine, guanethidine, debrisoquine, methyldopa, α- & β-adrenergic-blocking agents.